TY - SER AU - Koziol-McLain, Jane AU - Vandal, Alain C. AU - Wilson, Denise AU - Nada-Raja, Shyamala AU - Dobbs, Terry AU - McLean, Christine AU - Sisk, Rose AU - Eden, Karen E. AU - Glass, Nancy E. TI - Efficacy of a web-based safety decision aid for women experiencing intimate partner violence : : randomized controlled trial PY - 2018/// PB - JMIR Publications, KW - ONLINE TOOLS KW - ABUSED WOMEN KW - DEPRESSION KW - DOMESTIC VIOLENCE KW - EVALUATION KW - INTERVENTION KW - INTIMATE PARTNER VIOLENCE KW - MĀORI KW - RANDOMISED CONTROLLED TRIALS KW - SAFETY PLANNING KW - HAUMARUTANGA KW - NGĀKAU PŌURI KW - TRH KW - PĀRURENGA KW - reo KW - RANGAHAU MĀORI KW - RAUEMI-Ā-IPURANGI KW - TŪKINOTANGA Ā-WHĀNAU KW - WĀHINE KW - NEW ZEALAND N1 - Journal of Medical Internet Research, 2018, 20(1): e8 N2 - Background: Intimate partner violence (IPV) is a human rights violation and leading health burden for women. Safety planning is a hallmark of specialist family violence intervention, yet only a small proportion of women access formal services. A Web-based safety decision aid may reach a wide audience of women experiencing IPV and offer the opportunity to prioritize and plan for safety for themselves and their families. Objective: The aim of this study was to test the efficacy of a Web-based safety decision aid (isafe) for women experiencing IPV. Methods: We conducted a fully automated Web-based two-arm parallel randomized controlled trial (RCT) in a general population of New Zealand women who had experienced IPV in the past 6 months. Computer-generated randomization was based on a minimization scheme with stratification by severity of violence and children. Women were randomly assigned to the password-protected intervention website (safety priority setting, danger assessment, and tailored action plan components) or control website (standard, nonindividualized information). Primary endpoints were self-reported mental health (Center for Epidemiologic Studies Depression Scale-Revised, CESD-R) and IPV exposure (Severity of Violence Against Women Scale, SVAWS) at 12-month follow-up. Analyses were by intention to treat. Results: Women were recruited from September 2012 to September 2014. Participants were aged between 16 and 60 years, 27% (111/412) self-identified as Māori (indigenous New Zealand), and 51% (210/412) reported at baseline that they were unsure of their future plans for their partner relationship. Among the 412 women recruited, retention at 12 months was 87%. The adjusted estimated intervention effect for SVAWS was −12.44 (95% CI −23.35 to −1.54) for Māori and 0.76 (95% CI −5.57 to 7.09) for non-Māori. The adjusted intervention effect for CESD-R was −7.75 (95% CI −15.57 to 0.07) for Māori and 1.36 (−3.16 to 5.88) for non-Māori. No study-related adverse events were reported. Conclusions: The interactive, individualized Web-based isafe decision aid was effective in reducing IPV exposure limited to indigenous Māori women. Discovery of a treatment effect in a population group that experiences significant health disparities is a welcome, important finding. (Authors' abstract). Record #5720 UR - http://www.jmir.org/2018/1/e8/ ER -